Amgen Undercuts Its Buy Point On Mixed Second-Quarter Report
Amgen stock fell late Tuesday after the biotech reported lighter-than-expected second-quarter profits, though sales beat. The post Amgen Undercuts Its Buy Point On Mixed Second-Quarter Report appeared first on Investor's Business Daily.
Amgen stock fell late Tuesday after the biotech reported lighter-than-expected second-quarter profits, though sales beat.
The post Amgen Undercuts Its Buy Point On Mixed Second-Quarter Report appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
